EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insulin Resistance in Systemic Sclerosis: Decoding Its Association with Severe Clinical Phenotype

Eugenio Capparelli iD, Luca Clerici, Giusy Cinzia Moltisanti, Francesco Lapia, Eleonora Zaccara, Francesca Capelli, Daniela Bompane, Maria Sole Chimenti iD, Sergio Finazzi, Paola Maria Luigia Faggioli, Antonino Mazzone

Journal of Clinical Medicine · 17.01.2026 · 15 (2) · 774

DOI: 10.3390/jcm15020774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.01.2026. Verfasst von Eugenio Capparelli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, ASST Ovest Milanese, Legnano Hospital, 20025 Milan, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Insulin resistance (IR) is a relevant metabolic concern in patients with rheumatic diseases; however, data regarding its clinical influence on the systemic sclerosis (SSc) phenotype is lacking. This study aimed to evaluate the characteristics of patients exhibiting IR in a monocentric SSc cohort.

Methods

We conducted a cross-sectional study on 178 SSc patients, stratified according to the presence of IR, defined as a HOMA-IR value >1.85 for men and >2.07 for women, based on thresholds previously validated in the Estudio Epidemiológico de la Insuficiencia Renal en España (EPIRCE) cross-sectional study. The rationale for applying the current cut-offs is based on its discriminative potential when using sex- and age-specific thresholds in a nondiabetic population. This approach is particularly applicable to SSc, where the prevalence of diabetes is very low and the median ages of the two cohorts are comparable. Data collected included demographic-, clinical-, laboratory-, pulmonary function-, capillaroscopic-, and treatment-related parameters. A multivariable logistic regression model was used to identify independent predictors of IR.

Results

Patients with IR (n = 76) had a significantly higher prevalence of diffuse cutaneous subset (26.3% vs. 11.8%, p = 0.012) and interstitial lung disease (39.5% vs. 17.6%, p = 0.001), along with the positivity for anti-Scl70 antibodies and the current presence of musculoskeletal symptoms (p = 0.021) and digital ulcers (p = 0.037). As expected, body mass index (BMI) was significantly higher in the IR population (24.6 ± 5.2 vs. 22.9 ± 4.1, p = 0.012), along with fasting glucose, insulin, HOMA-IR, and HbA1c levels. IR patients exhibited higher percentages of dyslipidemia and liver steatosis. Medications such as hydroxychloroquine, statins, and Iloprost were more frequently used in the IR group; as for corticosteroids usage (21.1% vs. 5.9%, p = 0.002), however, cumulative glucocorticoid dosage did not differ between the groups. In multivariable analysis, BMI (OR 1.09; p = 0.038) and interstitial lung disease (ILD) (OR 3.03; p = 0.034) were independent predictors of IR.

Conclusions

In SSc, IR is associated with ILD, digital ulcers, musculoskeletal involvement, and anti-Scl70 autoantibodies.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular eventsendothelial dysfunctioninsulin resistancelung involvementmetabolic syndromesystemic sclerosisvascular impairment

Autor:innen und Institutionen

  • Rheumatology Unit, ASST Ovest Milanese, Legnano Hospital, 20025 Milan, Italy.
  • Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Internal Medicine Unit, ASST Ovest Milanese, Legnano Hospital, Via Papa Giovanni Paolo II, 20025 Milan, Italy.
  • Department of Internal Medicine and Medical Therapeutics, University of Pavia, 27100 Pavia, Italy.
  • Laboratory of Clinical Chemistry, ASST Ovest Milanese, Hospital of Legnano, 20025 Milan, Italy.

ORCID-Profile: Eugenio Capparelli, Maria Sole Chimenti

Zitieren

APA

Capparelli, E., Clerici, L., Moltisanti, G. C., Lapia, F., Zaccara, E., Capelli, F., Bompane, D., Chimenti, M. S., Finazzi, S., Faggioli, P. M. L., & Mazzone, A. (2026). Insulin Resistance in Systemic Sclerosis: Decoding Its Association with Severe Clinical Phenotype. Journal of Clinical Medicine, 15(2), 774. https://doi.org/10.3390/jcm15020774

Vancouver

Capparelli E, Clerici L, Moltisanti GC, Lapia F, Zaccara E, Capelli F, et al. Insulin Resistance in Systemic Sclerosis: Decoding Its Association with Severe Clinical Phenotype. Journal of Clinical Medicine. 2026;15(2):774. doi:10.3390/jcm15020774

BibTeX
@article{Capparelli2026,
  author = {Capparelli, Eugenio and Clerici, Luca and Moltisanti, Giusy Cinzia and Lapia, Francesco and Zaccara, Eleonora and Capelli, Francesca and Bompane, Daniela and Chimenti, Maria Sole and Finazzi, Sergio and Faggioli, Paola Maria Luigia and Mazzone, Antonino},
  title = {Insulin Resistance in Systemic Sclerosis: Decoding Its Association with Severe Clinical Phenotype},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {774},
  doi = {10.3390/jcm15020774}
}
Kostenlos starten →